Literature DB >> 12578867

Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions.

Kikuo Isoda1, Yashuhiro Kamezawa, Makoto Ayaori, Masatoshi Kusuhara, Norihiro Tada, Fumitaka Ohsuzu.   

Abstract

BACKGROUND: Osteopontin (OPN) is a noncollagenous adhesion protein found at the site of atherosclerotic lesions. However, it has not yet been clarified whether or not OPN can promote atherosclerotic lesions. METHODS AND RESULTS We investigated the contribution of OPN to atherosclerosis by evaluating aortic sinus lesions of both OPN transgenic (Tg) and non-Tg mice fed an atherogenic diet (1.25% cholesterol) for 16 weeks. The atherosclerotic lesions were found to be significantly larger in OPN-Tg compared with those in non-Tg (17,859+/-2010 versus 6469+/-485 micro m(2), P<0.01). The lesions in both mice were fatty-streak lesions with an accumulation of mononuclear cells and lipids. We next investigated the production of interleukin (IL)-10 by macrophages from both mice. Compared with the non-Tg mice, a 42% (P<0.01) and 73% (P<0.001) decrease in the IL-10 production was identified in the OPN-Tg mice either without or with lipopolysaccharide.
CONCLUSIONS: The expression of OPN induces fatty-streak lesion formation in mice fed an atherogenic diet and inhibits IL-10 production by macrophages, thus suggesting that OPN plays an important role in the development of fatty-streak lesions in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578867     DOI: 10.1161/01.cir.0000055739.13639.d7

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  27 in total

1.  Relationship of osteopontin and renal function with severity of coronary artery lesions.

Authors:  Jian Chen; Yingmin Lu; Damin Huang; Xiaohan Luo; Yachen Zhang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  Osteopontin: an emerging therapeutic target in uraemic vascular disease.

Authors:  Xin Zhang; Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Cardiovasc Res       Date:  2013-04-23       Impact factor: 10.787

3.  The elevated expression of osteopontin and NF-κB in human aortic aneurysms and its implication.

Authors:  Tao Mi; Bin Nie; Cuntai Zhang; Honglian Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25

4.  Molecular evidence for arterial repair in atherosclerosis.

Authors:  Ravi Karra; Sreekanth Vemullapalli; Chunming Dong; Edward E Herderick; Xiaohua Song; Kathy Slosek; Joseph R Nevins; Mike West; Pascal J Goldschmidt-Clermont; David Seo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

5.  Role of osteopontin in amplification and perpetuation of rheumatoid synovitis.

Authors:  Guangwu Xu; Hong Nie; Ningli Li; Wenxin Zheng; Dongqing Zhang; Guozhang Feng; Liqing Ni; Rong Xu; Jian Hong; Jingwu Z Zhang
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

6.  Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.

Authors:  Dennis Bruemmer; Alan R Collins; Grace Noh; Wei Wang; Mary Territo; Sarah Arias-Magallona; Michael C Fishbein; Florian Blaschke; Ulrich Kintscher; Kristof Graf; Ronald E Law; Willa A Hsueh
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  Differential effects of high-fat-diet rich in lard oil or soybean oil on osteopontin expression and inflammation of adipose tissue in diet-induced obese rats.

Authors:  Xiaoke Wang; Mengjie Cheng; Min Zhao; Aiguo Ge; Fangfang Guo; Min Zhang; Yanhong Yang; Liegang Liu; Nianhong Yang
Journal:  Eur J Nutr       Date:  2012-07-31       Impact factor: 5.614

8.  Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis.

Authors:  Yukihiko Momiyama; Reiko Ohmori; Zahi A Fayad; Teruyoshi Kihara; Nobukiyo Tanaka; Ryuichi Kato; Hiroaki Taniguchi; Masayoshi Nagata; Haruo Nakamura; Fumitaka Ohsuzu
Journal:  Atherosclerosis       Date:  2010-01-04       Impact factor: 5.162

9.  Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2.

Authors:  Simone H Mangan; Ann Van Campenhout; Catherine Rush; Jonathan Golledge
Journal:  Cardiovasc Res       Date:  2007-08-02       Impact factor: 10.787

10.  Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance.

Authors:  Florian W Kiefer; Maximilian Zeyda; Karina Gollinger; Birgit Pfau; Angelika Neuhofer; Thomas Weichhart; Marcus D Säemann; René Geyeregger; Michaela Schlederer; Lukas Kenner; Thomas M Stulnig
Journal:  Diabetes       Date:  2010-01-27       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.